Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Oct 25;13(11):2151.
doi: 10.3390/v13112151.

COVEVOL: Natural Evolution at 6 Months of COVID-19

Affiliations
Observational Study

COVEVOL: Natural Evolution at 6 Months of COVID-19

Louise Messin et al. Viruses. .

Abstract

Many studies have investigated post-COVID symptoms, but the predictors of symptom persistence remain unknown. The objective was to describe the natural course of the disease at 6 months and to identify possible factors favoring the resurgence or persistence of these symptoms. COVEVOL is a retrospective observational descriptive study of 74 patients. All patients with positive SARS-CoV-2 PCR from March 2020 were included. We compared a group with symptom persistence (PS group) with another group without symptom persistence (no-PS group). Fifty-three out of seventy-four patients (71.62%) described at least one persistent symptom at 6 months of SARS-CoV-2 infection. In the PS group, 56.6% were women and the average age was 54.7 years old [21-89.2] ± 16.9. The main symptoms were asthenia (56.6%, n = 30), dyspnea (34%, n = 18), anxiety (32.1% n = 17), anosmia (24.5%, n = 13) and agueusia (15.1% n = 8). Ten patients (13.51%) presented a resurgence in symptoms. Patients in the PS group were older (p = 0.0048), had a higher BMI (p = 0.0071), and were more frequently hospitalized (p = 0.0359) compared to the no-PS group. Odynophagia and nasal obstruction were less present in the inaugural symptoms of COVID-19 in the PS group (p = 0.0202 and p = 0.0332). Persistent post-COVID syndromes are common and identification of contributing factors is necessary for understanding this phenomenon and appropriate management.

Keywords: anosmia; anxiety; asthenia; dyspnea; persistent symptoms; post-COVID-19; risk factors; “long COVID”.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow Chart.
Figure 2
Figure 2
Proportion of persistent symptoms in the persistent symptom group (n = 53) after SARS-CoV-2 infection. ENT (ear, nose and throat) symptoms: nasal obstruction, nasal pain, rhinorrhea, nasal dryness, sneezing, odynophagia, dysphonia. Cardiologic symptoms: chest pain, palpitations, lipothymia. Neurologic symptoms: headache, dizziness, drowsiness. Neuropathic pain: myalgias, paresthesias of the limbs. Psychiatric symptoms: depressive syndrome, memory impairment, attention deficit. Other symptoms: epicondylitis, erectile dysfunction.

Similar articles

Cited by

References

    1. Shereen M.A., Khan S., Kazmi A., Bashir N., Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J. Adv. Res. 2020;24:91–98. doi: 10.1016/j.jare.2020.03.005. - DOI - PMC - PubMed
    1. Allocution Liminaire du Directeur Général de l’OMS Lors du Point Presse sur la COVID-19. 2020. [(accessed on 11 March 2020)]. Available online: https://www.who.int/fr/director-general/speeches/detail/who-director-gen....
    1. Desvaux É., Faucher J.-F. Covid-19: Aspects cliniques et principaux éléments de prise en charge. Rev. Francoph. Lab. 2020;2020:40–47. doi: 10.1016/S1773-035X(20)30312-9. - DOI - PMC - PubMed
    1. Guan W., Liang W., Zhao Y., Liang H., Chen Z., Li Y. Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis. [(accessed on 10 February 2021)];Eur. Respir. J. 2020 55:2000547. doi: 10.1183/13993003.00547-2020. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098485/ - DOI - PMC - PubMed
    1. Coronavirus: Chiffres Clés et Évolution de la COVID-19 en France et dans le Monde. [(accessed on 10 February 2021)]. Available online: https://dossiers/coronavirus-covid-19/coronavirus-chiffres-cles-et-evolu....

Publication types